P1058: REAL-WORLD OUTCOMES WITH FEDRATINIB THERAPY IN PATIENTS WITH PRIMARY MYELOFIBROSIS POST-RUXOLITINIB DISCONTINUATION. (23rd June 2022) - Passamonti, F.; Lou, Y.; Chevli, M.; Abraham, P.